Bovine herpesvirus 1 (BHV-1), a significant cause of morbidity and an economically important pathogen of cattle, is associated with a variety of disease manifestations including rhinotracheitis, conjunctivitis, reproductive tract lesions, and encephalitis (2, 11) . The viral particle exhibiting a typical herpesvirus morphology consists of a double-stranded DNA molecule contained in a 100-nm icosahedric capsid surrounded by an envelope. Hemagglutinating activity has been recently associated with a few Russian BHV-1 strains (5) and subsequently with several North American strains (13) for C57Br or C57BL mouse erythrocytes. BHV-1 strain P8-2 or Los Angeles has been reported to be composed of 21 to 33 structural proteins (9, 10) . However, limited data are available regarding the variability of structural proteins and antigenic determinants among viral strains. Such information was analyzed in the present report on different North American BHV-1 strains.
Fourteen BHV-1 strains (infectious bovine rhinotracheitis virus) were used in this study. The Los Angeles (ATCC VR-188) and Cooper 1 (ATCC VR-864) reference strains were obtained from the American Type Culture Collection (Rockville, Md.). All others were Canadian field isolates obtained from various sources as described previously (13 cells per ml was added to each well, and the plates were incubated at 37°C in a 5% CO, atmosphere and checked for cytopathic effect after 4 days. The assay was done in quadruplicate, with viral suspensions without mouse ascitic fluid serving as controls. HI assays were performed in microtiter plates with kaolin-treated monoclonal antibodies as described previously (M. Trudel, C. Seguin, F. Nadon, G. Boulay, P. Trepanier, and G. Lussier, Vet. Microbiol., in press). Heterohemagglutinins were removed by adsorption with C57BL mouse erythrocytes. Briefly, 25 pL. of a suspension containing 4 hemagglutinating units of the different BHV-1 to be tested was added to 25 pL. of a 1:640 dilution of mouse ascitic fluid (IgM monoclonal antibody). The mixture was incubated overnight after which 50 .I1 of a 0.3% suspension of C57BL mouse erythrocytes was added. After 2 h at room temperature, the presence or absence of hemagglutinating activity was recorded.
The competitive inhibition enzyme-linked immunosorbent assay was done as described by Talbot et al. (12) . We labeled monoclonal antibodies with horseradish peroxidase after evaluating the concentration of the antibodies by radial immunodiffusion against goat anti-mouse IgG or IgM (Meloy Laboratories. Springfield, Va.). The competing unlabeled monoclonal antibody was incubated with the antigen-coated plates, and the horseradish peroxidase-conjugated monoclonal antibody was then added to the wells. The reaction was developed after washing with o-phenylenediamine (0.4 mg/ml) in 0.1 M citrate buffer (pH 5). The enzymatic reaction was terminated after 30 min by adding 0.1 ml of 1 N HCI to each well. Optical densities at 492 nm were read with a Titertek Multiscan photometer (Flow Laboratories).
The intracellular proteins of all 14 viral strains studied are depicted in Fig. 1 . The overall polypeptide profiles were similar, with no major differences noted between the Los Angeles and Cooper 1 reference strains and the Canadian field isolates. Heavily labeled major viral proteins consistently seen in all of the strains were easily identified as compared with the cellular control. A few slight variations could be observed among some strains involving either the absence or different mobilities of some minor proteins as indicated by arrowheads in Fig. 1 . The presence of a major 45-kilodalton (kDa) cellular protein was also seen in all of the strains. BHV-1 structural proteins were analyzed after extracellular virus was pelleted through a 25% cushion of potassium tartrate (viral isodensity was about 30%). This approach proved quite successful in generating concentrated, intact virus preparations almost devoid of any contaminating material. Electrophoresis of such viral preparations (Fig. 2) showed that the polypeptide profiles were identical for all strains but with fewer proteins compared (Fig.  2, lane C, arrow) . However, partly purified virus was devoid of most intracellular polypeptides previously seen in the 12-to 30-kDa region and which probably represented precursor degradation and cellular and viral breakdown products from larger polypeptides. Very high-molecular-weight structural proteins were also less abundant; those observed were, however, too poorly resolved to differentiate them from those in the cellular control.
Using the viral strains reported here, we then proceeded to verify the extent of neutralizing and HI capabilities of two monoclonal antibodies produced against the Cooper 1 strain. The neutralizing IgG-1 monoclonal antibody used was able to neutralize 50 PFU of the Los Angeles reference strain as well as the other 12 Canadian field isolates equally (Table 1) . Similarly, the HI IgM monoclonal antibody was able to inhibit hemagglutination of 4 hemagglutinating units of all other BHV-1 strains tested.
We subsequently used these monoclonal antibodies in immunoprecipitation studies to identify the polypeptide(s) carrying the neutralization and hemagglutination epitopes. With all of the viral strains used here, the neutralizing and HI monoclonal antibodies immunoprecipitated the 90-kDa polypeptides; an example of the latter using three different strains, that is, the homologous Cooper 1 strain, the Los Angeles reference strain, and field isolate no 7, is shown in Fig. 3 . Furthermore, the competitive inhibition enzymelinked immunosorbent assay revealed that the neutralization and hemagglutination epitopes were located in two different antigenic regions since competition was seen only with the homologous monoclonal antibody and no competition was obtained between the two monoclonal antibodies with horseradish peroxidase-labeled IgM (Fig. 4) 
